Bibb Medical Center is an Alabama health care provider participating with Eli Lilly company in an FDA authorized trial to provide specialized infusion therapy to pre-hospital patients under certain conditions who have a positive COVID test. The Bibb Voice sat down with Chelsea Barton, CRNP from Bibb Medical Center to talk about the work that she has been doing with patients at BMC. Click on the link above to see the short video.
The pharmaceutical company released this information about the trial:
An antibody cocktail developed by Eli Lilly significantly reduced Covid-19-related hospitalizations and deaths in high-risk patients, the company announced Tuesday.
Data from more than 1,000 patients enrolled in Lilly’s late-stage study found that the antibody cocktail reduced viral load and accelerated symptom resolution.